GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cortex Pharmaceuticals, Inc. (COR) [hlAlert]

Cortex Pharmaceuticals, Inc. (Cortex) focuses on developing small molecule compounds that positively modulate AMPA-type glutamate receptors, a complex of proteins involved in the communication between nerve cells in the mammalian brain. These compounds, termed AMPAKINE compounds, enhance the activity of the AMPA
receptor. The Company designs and develops these molecules as pharmaceuticals intended for the treatment of neurological and psychiatric diseases, and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter. The Company?s clinical compound, CX717 is in Phase II clinical development. Diseases, such as alzheimer?s disease, mild cognitive impairment (MCI), attention deficit hyperactivity disorder (ADHD), schizophrenia, depression, respiratory depression caused by opiate analgesics, and possibly sleep apnea may benefit from treatment with AMPAKINE drugs.
.
( Total: 11 Current Stock Recommendations )
Cortex Pharmaceuticals, Inc.   (11)
Sell Hold 45% Buy 45%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
4/4/2013  
Hold
  
10/16/2013  
Hold
  
4/29/2013  
Buy
  
10/22/2013  
Hold
  
12/16/2010  
Buy
  
6/5/2008  
Hold
  
4/5/2013  
Sell
  
11/5/2010  
Buy
  
1/14/2011  
Hold
  
1/15/2013  
Buy
  
11/12/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy